The effect of differences in the third domain of the glycoprotein E of tick-borne encephalitis virus of the Far Eastern, Siberian and European subtypes on the binding of recombinant D3 proteins with a chimeric antibody
Open Access
- 14 May 2019
- journal article
- research article
- Published by Institute of Cytology and Genetics, SB RAS in Vavilov Journal of Genetics and Breeding
- Vol. 23 (3) , 256-261
Abstract
Currently, a therapeutic drug based on recombinant antibodies for the prevention and treatment of tick-borne encephalitis virus (TBEV) is developed in ICBFM SB RAS, and the chimeric antibody ch14D5 is considered as one of the key components of this drug. It was previously shown that this antibody is directed to the domain D3 of the glycoprotein E of TBEV. It was previously shown that this antibody is able to protect mice from the European subtype of TBEV, strain “Absettarov”, and the presence of virus-neutralizing activity against the Far Eastern subtype of TBEV, strain 205 was also shown for this antibody. However, it remains unclear whether this antibody exhibits selectivity for different subtypes of TBEV. The aim of this study was to investigate the effect of amino acid sequence differences of recombinant D3 domains derived from the glycoprotein E of TBEV of the Far Eastern, Siberian and European subtypes on the binding of the protective antibody ch14D5 to these proteins. Using Western blot analysis and surface plasmon resonance, it was shown that ch14D5 antibody has the highest affinity (KD= 1.7±0.5 nM) for the D3 domain of the TBEV of the “Sofjin-Ru” strain belonging to the Far Eastern subtype of the virus. At the same time, the affinity of ch14D5 antibody for similar D3 proteins derived from “Zausaev”, “1528-99” and “Absettarov” strains of the Siberian and European subtypes of TBEV was noticeably lower (KD= 25±4, 300±50, 250±50 nM, respectively). In addition, information about the spatial arrangement of amino acid residues that are different for the studied recombinant proteins indicates that the epitope recognized by the ch14D5 antibody is in close proximity to the lateral ridge of D3 domain of E glycoprotein.Keywords
This publication has 21 references indexed in Scilit:
- A protective chimeric antibody to tick-borne encephalitis virusVaccine, 2014
- Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal modelAntiviral Research, 2014
- Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus InfectionsBioMed Research International, 2013
- Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular designProtein Engineering, Design and Selection, 2013
- Flaviviruses and their antigenic structureJournal of Clinical Virology, 2012
- Antibody-mediated neutralization of flaviviruses: A reductionist viewVirology, 2011
- Chimeric antibodies against tick-borne encephalitis virusVaccine, 2010
- Monoclonal antibody produced in plants efficiently treats West Nile virus infection in miceProceedings of the National Academy of Sciences, 2010
- Characterization of neutralizing antibodies to West Nile virusVirology, 2005
- Epitope analysis of tick-borne encephalitis (TBE) complex viruses using monoclonal antibodies to envelope glycoprotein of TBE virus (persulcatus subtype)Virus Research, 1993